KIMBERLY BRAVO: Open Payments
NPI 1447270400 · HILLIARD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 14 payments from 9 companies in 2025. Trend: 2023 $1,988 · 2024 $1,478 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $427 |
| Stryker Corporation | 1 | $140 |
| Novo Nordisk Inc | 1 | $124 |
| Medtronic, Inc. | 1 | $74 |
| Corcept Therapeutics | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: LIMFLOW SYSTEM, AIRSUPRA, BREZTRI, TEZSPIRE, Ozempic, INTELLIS ADAPTIVESTIM, Korlym, FARXIGA.
Industry payments across FL — which companies pay providers there.
